Update October 2018:
Clinical practice guidelines on the management of cyclic vomiting syndrome in adults. A note about progress with the CVS guidelines for adults – The four articles listed below have been completed and submitted to the governing Council of the American Neurogastroenterology and Motility Society (ANMS) – the sponsoring body. These are to be published in a special supplement to the Journal of Neurogastroenterology and Motility. Hopefully this set of articles will be published with open access in early 2019. The submitted draft will be circulated within the ANMS Council for comment. Requests for edits may be submitted back to the developing committee. On completion of the final draft, the documents will be submitted to the publisher of the journal.
1. Guidelines on Management of Cyclic Vomiting Syndrome in Adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association 2. Technical Review on Pharmacologic Agents Used as Therapy in the Management of CVS 3. Role of Cannabis Use: Cyclic Vomiting Syndrome vs. Cannabinoid Hyperemesis Syndrome 4. Pathophysiology of CVS: Current Knowledge, Gaps in Understanding, and Future Directions
Update September 2018:
Over the last three years, you may have been following the progress of this landmark project for adult patients with CVS worldwide. The American Neurogastroenterology and Motility Society (ANMS) with scientific sponsorship, and CVSA with financial and logistical sponsorship, have teamed up. The result will soon be available as a special supplement to the Journal of Neuro-gastroenterology and Motility. The contents of the supplement:
1. Guidelines on Management of Cyclic Vomiting Syndrome in Adults
2. Technical Review on Pharmacologic Agents Used as Therapy in the Management of CVS
3. Role of Cannabis Use: Cyclic Vomiting Syndrome vs. Cannabinoid Hyperemesis Syndrome
4. Pathophysiology of CVS: Current Knowledge, Gaps in Understanding, and Future Directions
This extremely important and useful set of documents is dedicated to honor David R. Fleisher, M.D. who has spent his entire career of over 50 years — and still counting — working passionately and tirelessly on behalf of patients with CVS. He will be honored in print within the document.
Update October 2017:
Once or twice a month, conference calls have been held along with in-person meetings. Tireless work has been completed on the available literature search and evaluation of relevant articles. This process must be completed before the work of writing the document can commence. Yet to be published, relevant articles are being considered as they become available.
The process used in evidence-based practice to frame and answer a clinical or healthcare-related question and background questions have been completed. This framework is also used to develop literature search strategies. The first draft of the main manuscript incorporating background questions is being completed by the committee.
Because of an emerging decision by the publication board of the journal of choice for the final document, Neurogastroenterology and Motility, there may be good news coming of an agreement between the committee and the publisher that would expand the usefulness of this document beyond what we originally expected. Stay tuned for that news.
Again, like the consensus statement for the diagnosis and treatment for CVS in children, this resulting document will provide an excellent resource for clinicians diagnosing and treating CVS in adults around the world. We thank the financial donors for this project for their generosity in making this all possible for the benefit of many. We also thank the tireless efforts of all the committee members.